Evidence map›Paper›PMID 37128221›Full record

ArticleGlobal health & medicine2023

Evolving partnership: A National Center for Global Health and Medicine Resilient Training Model for clinical research professionals during the COVID-19 pandemic.

Sifa Marie Joelle Muchanga, Mieko Hamana, Marlinang Diarta Siburian, Maria Ruriko Umano, Nattha Kerdsakundee, Maria Rejane Umano, Masato Ichikawa, Tatsuo Iiyama

Open access · bronzeAbstract read
In one paragraph

Article in Global health & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sifa Marie Joelle MuchangaDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Mieko HamanaDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Marlinang Diarta SiburianDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Maria Ruriko UmanoDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Nattha KerdsakundeeDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Maria Rejane UmanoDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Masato IchikawaDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
Tatsuo IiyamaDepartment of International Trials, National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical trial industry has encountered challenging circumstances in which the increasing number of trials outpaces the number of trial specialists. For instance, there has been an unprecedented demand for clinical trials following the Covid-19 pandemic, which has worsened the global shortage of qualified personnel. It is therefore imperative to produce more qualified clinical trial professionals. An adaptive and collaborative training model was implemented by the National Center for Global Health and Medicine through the Department of International Trials. This aimed at building capacity among health workers in developing countries and providing them with the skills to be able to conduct all phases of the clinical trial from protocol design to publication of results. It also seeks to foster collaboration and partnership between local health workers and international experts. Since 2016, we have implemented a Japan-led training program, and since 2020, the COVID-19 pandemic has ushered in a shift from a single Train-the-trainer model (ToT) to a mixed model, the Evolving Partnership Training (ePT). In this model, we applied four different methods: train-the-trainer, needs-oriented training, open symposiums, and advanced learning. The total number of training participants increased exponentially from a total of 41 between 2016-2020 to 2,810 in 2021. Our experience has proven that despite the constraint of the pandemic, the ePT is a viable approach compared to a single method for providing quality training and increasing the number of participants.

Indexed as

clinical trial professionalsevolving partnership trainingNational Center for Global Health and Medicinetrainingtrain-the-trainer

Identifiers

PMID37128221
PMCPMC10130547
OpenAlexW4365131241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.